Navigation Links
Amicus Therapeutics Announces Transition of John F. Crowley from Chairman and Chief Executive Officer to Executive Chairman
Date:4/18/2011

and has been instrumental in its growth during his six and a half years at the Company," said Mr. Crowley. "He has a strong track record of success throughout his 18-year career in the field of rare disease drug development, having overseen the advancement of novel therapies through development into commercialization. I am confident Matt has the experience and capabilities to lead Amicus during this important time in the Company's history."

Mr. Patterson joined Amicus in December 2004 as Chief Business Officer and became Chief Operating Officer in September 2006. He was recently appointed President in February 2011 in recognition of his significant contributions to the Company's success. Prior to Amicus, Mr. Patterson served in positions of increasing responsibility at biopharmaceutical companies focused on rare disease drug research, development, and commercialization, including BioMarin Pharmaceutical Inc. and Genzyme Corporation.

Mr. Crowley will serve as Executive Chairman and a member of the Board of Directors until October 2011, with a possible extension for up to three months upon the mutual agreement of Mr. Crowley and the Company.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company at the forefront of developing therapies for rare diseases.  The Company is developing orally-administered, small molecule drugs called pharmacological chaperones, a novel, first-in-class approach to treating a broad range of diseases including lysosomal storage disorders and diseases of neurodegeneration. Amicus' lead program is in Phase 3 for the treatment of Fabry disease. 

FOLD-G


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease
2. Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal™ Co-administered with Enzyme Replacement Therapy
3. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
4. Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinsons Disease
5. Amicus Therapeutics Announces Third Quarter 2010 Financial Results
6. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
7. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
8. Amicus Therapeutics to Host Its Second Quarter 2010 Financial Results Conference Call and Webcast on August 5, 2010
9. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
10. Alzheimers Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology
11. Fenwal Receives FDA Clearance for Amicus(R) Separator With Wireless Connectivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ... Executive Officer, will be presenting at the 26 th ... Hotel in New York . The formal ... PM ET. In addition, Mr. Krakauer and Jorgen B. ... one-on-one meetings during the day. An audio ...
(Date:11/21/2014)... LAVAL, QC , Nov. 20, 2014 /CNW Telbec/ ... pleased to announce the following appointments: ... leadership team in the newly created role of Chief ... a BioPhotonic system using topical photoconverter gel for the ... as surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... , 21. November 2014 Michael DeMarco ... am Morgen des 14. Februar 2014 zugetragen hat. Seine ... kaum vergessen. Video - http://youtu.be/5cVoMCe0uiE ... dabei war, mein morgendliches Training zu machen", erzählt ... der Zeit begeisterte Anhänger der CrossFit-Trainingsmethode. Ich ...
Breaking Medicine Technology:KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3
... (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical firm developing vaccines to ... announced that the NIH-funded HIV Vaccine Trials Network (HVTN) ... the company,s second-generation HIV vaccine. The second-generation vaccine is ... a Phase 2a clinical trial) except for the inclusion ...
... -- Gentech Pharmaceutical announced today that Dr. Stan Headley ... PhenTabz and ADDTabz ... the world of Integrative Medicine. He holds a Doctorate of ... family medicine at Creighton University School of Medicine and St. ...
Cached Medicine Technology:HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 2HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 4Gentech Pharmaceutical Appoints New Medical Director for PhenTabz/ADDTabz 2
(Date:11/21/2014)... (HealthDay News) -- The cost of diabetes care in ... years, climbing to more than $322 billion annually, a ... were seen with prediabetes care, which have risen 74 ... the researchers added. In 2012, excess medical costs ... $1,000 for every American. That total includes $244 billion ...
(Date:11/21/2014)... Nov. 21, 2014 (HealthDay News) -- Scientists say they,ve mapped ... extracted from a British man,s brain, in hopes it might ... Nov. 21 in the journal Genome Biology , the ... man of Chinese ethnicity. "This infection is so rare ... was not diagnosed ... until the worm was pulled out ...
(Date:11/21/2014)... 21, 2014 MLF Biotech, Inc. has ... . Liv-Pro® Probiotics for Pets helps maintain digestive health ... a pet's intestinal flora after it experiences a period ... Liv-Pro Probiotics for Pets is a proprietary blend of ... seven live active bacteria strains that are safe and ...
(Date:11/21/2014)... November 21, 2014 Saint Luke’s ... With The Guidelines®–Heart Failure Gold-Plus Quality Achievement Award ... the American Heart Association/American College of Cardiology Foundation ... patients. , Get With The Guidelines–Heart Failure is ... provide the most up-to-date, research-based guidelines with the ...
(Date:11/21/2014)... Big Bud Farms announced today that ... Innovations with Ed Begley Jr., airing via Discovery Channel ... Big Bud Farms, growers of legal medical marijuana, provide ... of medical marijuana. , This segment of Innovations takes ... of products for medicating. Viewers will learn about the ...
Breaking Medicine News(10 mins):Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2
... found that the frequency with which critically-ill patients developed ... multidisciplinary medical center such as Mayo Clinic compared to ... National Healthcare Safety Network (NHSN). This is good news ... generally strong across the U.S. in intensive care units, ...
... children becoming unconscious after swallowing Aqua Dots beads led to ... the time, it was widely reported that the potentially toxic ... benign but more expensive 1,5-pentanediol (PD) in the manufacture of ... Suchard of the University of California, Irvine confirms these reports, ...
... Nancy Pelosi,issued the following statement today following reports on ... health has been met with great concern., "Senator ... Americans and a,great fighter for America,s children, workers and ... serve him well in this,challenge., "Our thoughts and ...
... spine conference and exhibition draws specialists from across the ... ... Medical Werks, a leading provider of,ceramic components for motion preserving, total disc ... be held in Geneva, Switzerland, May 26-31., The foremost scientific societies ...
... of,America, Inc. today announced that Lindsay Goldberg has ... will use the funds to close,several identified acquisitions ... http://www.newscom.com/cgi-bin/prnh/20071218/CLTU087LOGO ), Ambulatory Services of ... care services in partnership with physicians. In,December 2007, ...
... Foundation,today released the following statement by its founder and ... learned today that Senator Kennedy, a champion for healthcare ... himself facing this,disease. I have no doubt that Senator ... strength that have shaped his lifelong service to this,nation ...
Cached Medicine News:Health News:Intensive care units' prevention of pneumonia in critically-ill patients generally strong 2Health News:Study finds that recalled Aqua Dots did contain poisonous chemical 2Health News:C5 Medical Werks Joins in Sponsoring SpineWeek 2008 in Geneva, Switzerland 2Health News:Ambulatory Services of America, Inc. Announces Investment by Lindsay Goldberg 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: